Cargando…

A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis

Linear IgA bullous dermatosis (LABD) is an autoimmune vesiculobullous disease, which is typically idiopathic but can also rarely be caused by medications or infections. Vancomycin is the most common drug associated with LABD. Lesions typically appear 24 hours to 15 days after the first dose of vanco...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Pinky, Swanson, Kurtis, Stromich, Jeremiah, Michalski, Basia M., Olasz, Edit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259662/
https://www.ncbi.nlm.nih.gov/pubmed/28168063
http://dx.doi.org/10.1155/2017/7318305
_version_ 1782499248023011328
author Jha, Pinky
Swanson, Kurtis
Stromich, Jeremiah
Michalski, Basia M.
Olasz, Edit
author_facet Jha, Pinky
Swanson, Kurtis
Stromich, Jeremiah
Michalski, Basia M.
Olasz, Edit
author_sort Jha, Pinky
collection PubMed
description Linear IgA bullous dermatosis (LABD) is an autoimmune vesiculobullous disease, which is typically idiopathic but can also rarely be caused by medications or infections. Vancomycin is the most common drug associated with LABD. Lesions typically appear 24 hours to 15 days after the first dose of vancomycin. It is best characterized pathologically by subepidermal bulla (blister) formation with linear IgA deposition at the dermoepidermal junction. Here we report an 86-year-old male with a history of left knee osteoarthritis who underwent a left knee arthroplasty and subsequently developed a prosthetic joint infection. This infection was treated with intravenous vancomycin as well as placement of a vancomycin impregnated joint spacer. Five days following initiation of antibiotic therapy, he presented with a vesiculobullous eruption on an erythematous base over his trunk, extremities, and oral mucosa. The eruption resolved completely when intravenous vancomycin was discontinued and colchicine treatment was begun. Curiously, complete resolution occurred despite the presence of the vancomycin containing joint spacer. The diagnosis of vancomycin-induced linear IgA bullous dermatosis was made based on characteristic clinical and histopathologic presentations.
format Online
Article
Text
id pubmed-5259662
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-52596622017-02-06 A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis Jha, Pinky Swanson, Kurtis Stromich, Jeremiah Michalski, Basia M. Olasz, Edit Case Rep Dermatol Med Case Report Linear IgA bullous dermatosis (LABD) is an autoimmune vesiculobullous disease, which is typically idiopathic but can also rarely be caused by medications or infections. Vancomycin is the most common drug associated with LABD. Lesions typically appear 24 hours to 15 days after the first dose of vancomycin. It is best characterized pathologically by subepidermal bulla (blister) formation with linear IgA deposition at the dermoepidermal junction. Here we report an 86-year-old male with a history of left knee osteoarthritis who underwent a left knee arthroplasty and subsequently developed a prosthetic joint infection. This infection was treated with intravenous vancomycin as well as placement of a vancomycin impregnated joint spacer. Five days following initiation of antibiotic therapy, he presented with a vesiculobullous eruption on an erythematous base over his trunk, extremities, and oral mucosa. The eruption resolved completely when intravenous vancomycin was discontinued and colchicine treatment was begun. Curiously, complete resolution occurred despite the presence of the vancomycin containing joint spacer. The diagnosis of vancomycin-induced linear IgA bullous dermatosis was made based on characteristic clinical and histopathologic presentations. Hindawi Publishing Corporation 2017 2017-01-10 /pmc/articles/PMC5259662/ /pubmed/28168063 http://dx.doi.org/10.1155/2017/7318305 Text en Copyright © 2017 Pinky Jha et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jha, Pinky
Swanson, Kurtis
Stromich, Jeremiah
Michalski, Basia M.
Olasz, Edit
A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis
title A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis
title_full A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis
title_fullStr A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis
title_full_unstemmed A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis
title_short A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis
title_sort rare case of vancomycin-induced linear immunoglobulin a bullous dermatosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259662/
https://www.ncbi.nlm.nih.gov/pubmed/28168063
http://dx.doi.org/10.1155/2017/7318305
work_keys_str_mv AT jhapinky ararecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT swansonkurtis ararecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT stromichjeremiah ararecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT michalskibasiam ararecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT olaszedit ararecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT jhapinky rarecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT swansonkurtis rarecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT stromichjeremiah rarecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT michalskibasiam rarecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis
AT olaszedit rarecaseofvancomycininducedlinearimmunoglobulinabullousdermatosis